CCM
Cullen Capital Management Portfolio holdings
AUM
$8.66B
This Quarter Return
+1.96%
1 Year Return
+9.53%
3 Year Return
+18.77%
5 Year Return
+91.5%
10 Year Return
+127.23%
AUM
$3.7B
AUM Growth
+$3.7B
(-2.8%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
31.82%
Holding
212
New
16
Increased
83
Reduced
41
Closed
12
Top Buys
| 1 |
Gen Digital
GEN
|
$17.7M |
| 2 |
BCE
BCE
|
$7.83M |
| 3 |
AstraZeneca
AZN
|
$6.33M |
| 4 |
NADL
North Atlantic Drilling Ltd
NADL
|
$6.31M |
| 5 |
Novartis
NVS
|
$3.19M |
Top Sells
| 1 |
Vodafone
VOD
|
$65.2M |
| 2 |
Boeing
BA
|
$64.1M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
$43M |
| 4 |
RTN
Raytheon Company
RTN
|
$38.6M |
| 5 |
Kimberly-Clark
KMB
|
$19.7M |
Sector Composition
| 1 | Healthcare | 13.27% |
| 2 | Energy | 11.42% |
| 3 | Financials | 10.88% |
| 4 | Industrials | 10.58% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $127M | 3.45% | 2,243,380 +1,080 | +0% | +$61.3K |
|
|
RTN
2
DELISTED
Raytheon Company
RTN
| $125M | 3.37% | 1,260,860 -390,420 | -24% | -$38.6M |
|
3
Eli Lilly
LLY
$657B
| $123M | 3.32% | 2,085,050 -700 | -0% | -$41.2K |
|
4
3M
MMM
$82.8B
| $121M | 3.29% | 895,370 -450 | -0.1% | -$61K |
|
5
Microsoft
MSFT
$3.77T
| $121M | 3.26% | 2,940,180 +28,700 | +1% | +$1.18M |
|
6
ConocoPhillips
COP
$124B
| $117M | 3.16% | 1,658,270 -79,570 | -5% | -$5.6M |
|
7
Johnson & Johnson
JNJ
$427B
| $115M | 3.1% | 1,168,020 -54,210 | -4% | -$5.33M |
|
8
Intel
INTC
$107B
| $112M | 3.03% | 4,334,200 +3,830 | +0.1% | +$98.9K |
|
|
9
BCE
BCE
$23.3B
| $110M | 2.96% | 2,538,320 +181,512 | +8% | +$7.83M |
|
10
GE Aerospace
GE
$292B
| $107M | 2.89% | 4,126,050 +1,350 | +0% | +$35K |
|
11
Altria Group
MO
$113B
| $107M | 2.89% | 2,851,480 +1,960 | +0.1% | +$73.4K |
|
12
JPMorgan Chase
JPM
$829B
| $106M | 2.87% | 1,745,790 +1,210 | +0.1% | +$73.5K |
|
13
Travelers Companies
TRV
$61.1B
| $102M | 2.76% | 1,198,730 +34,750 | +3% | +$2.96M |
|
|
14
AstraZeneca
AZN
$248B
| $101M | 2.72% | 1,550,900 +97,500 | +7% | +$6.33M |
|
|
DD
15
DELISTED
Du Pont De Nemours E I
DD
| $99.5M | 2.69% | 1,483,530 +1,120 | +0.1% | +$75.2K |
|
16
Chevron
CVX
$324B
| $98.9M | 2.68% | 832,130 +819 | +0.1% | +$97.4K |
|
17
Cisco
CSCO
$274B
| $98.2M | 2.66% | 4,382,450 +2,600 | +0.1% | +$58.3K |
|
18
AT&T
T
$209B
| $93.2M | 2.52% | 2,657,550 +730 | +0% | +$25.6K |
|
19
NextEra Energy, Inc.
NEE
$148B
| $90.5M | 2.45% | 946,510 +1,230 | +0.1% | +$118K |
|
20
MetLife
MET
$54.1B
| $88.5M | 2.4% | 1,676,680 +130 | +0% | +$6.86K |
|
|
RDS.B
21
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $87M | 2.35% | 1,113,280 -660 | -0.1% | -$51.6K |
|
22
HSBC
HSBC
$224B
| $84.7M | 2.29% | 1,665,480 +524 | +0% | +$26.6K |
|
|
UN
23
DELISTED
Unilever NV New York Registry Shares
UN
| $83.6M | 2.26% | 2,032,810 +2,260 | +0.1% | +$92.9K |
|
|
24
Kimberly-Clark
KMB
$42.8B
| $83.1M | 2.25% | 753,500 -179,080 | -19% | -$19.7M |
|
25
Philip Morris
PM
$260B
| $78.1M | 2.11% | 953,380 +1,780 | +0.2% | +$146K |
|